0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Substance Abuse and Addiction Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15N13643
Home | Market Reports | Sensitive Subjects
Global Substance Abuse and Addiction Treatment Market Research Report 2023
BUY CHAPTERS

Global Substance Abuse and Addiction Treatment Market Research Report 2025

Code: QYRE-Auto-15N13643
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Substance Abuse and Addiction Treatment Market Size

The global market for Substance Abuse and Addiction Treatment was valued at US$ 788 million in the year 2024 and is projected to reach a revised size of US$ 1209 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Substance Abuse and Addiction Treatment Market

Substance Abuse and Addiction Treatment Market

Drug addiction, also known as a substance use disorder, is a disorder that affects a person"s brain and behavior, resulting in an inability to control the use of legal or illegal drugs or drugs. Substances such as alcohol, marijuana, and nicotine are also considered drugs in this category. Over time, larger doses may be needed to get high. As your drug use increases, you may find it harder and harder to get off the drug. Trying to stop using the drug may cause intense cravings and make you feel physically ill (withdrawal symptoms)…
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Substance Abuse and Addiction Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Substance Abuse and Addiction Treatment.
The Substance Abuse and Addiction Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Substance Abuse and Addiction Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Substance Abuse and Addiction Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Substance Abuse and Addiction Treatment Market Report

Report Metric Details
Report Name Substance Abuse and Addiction Treatment Market
Accounted market size in year US$ 788 million
Forecasted market size in 2031 US$ 1209 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alkermes, Mallinckrodt, GSK, Cipla, Idiviour, Hager Biosciences,LLC, ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences,Inc., Cerecor,Inc, Astraea Therapeutics LLC, Pfizer Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, Mylan NV
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Substance Abuse and Addiction Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Substance Abuse and Addiction Treatment Market growing?

Ans: The Substance Abuse and Addiction Treatment Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Substance Abuse and Addiction Treatment Market size in 2031?

Ans: The Substance Abuse and Addiction Treatment Market size in 2031 will be US$ 1209 million.

Who are the main players in the Substance Abuse and Addiction Treatment Market report?

Ans: The main players in the Substance Abuse and Addiction Treatment Market are Alkermes, Mallinckrodt, GSK, Cipla, Idiviour, Hager Biosciences,LLC, ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences,Inc., Cerecor,Inc, Astraea Therapeutics LLC, Pfizer Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, Mylan NV

What are the Application segmentation covered in the Substance Abuse and Addiction Treatment Market report?

Ans: The Applications covered in the Substance Abuse and Addiction Treatment Market report are Hospital, Home Nursing, Specialist Clinic, Other

What are the Type segmentation covered in the Substance Abuse and Addiction Treatment Market report?

Ans: The Types covered in the Substance Abuse and Addiction Treatment Market report are Nicotine Replacement Therapy, Psychotherapy, Alcohol Addiction Treatment

Recommended Reports

Addiction & Mental Health

Pain & Neurology

Disorder Specific Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Substance Abuse and Addiction Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nicotine Replacement Therapy
1.2.3 Psychotherapy
1.2.4 Alcohol Addiction Treatment
1.3 Market by Application
1.3.1 Global Substance Abuse and Addiction Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home Nursing
1.3.4 Specialist Clinic
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Substance Abuse and Addiction Treatment Market Perspective (2020-2031)
2.2 Global Substance Abuse and Addiction Treatment Growth Trends by Region
2.2.1 Global Substance Abuse and Addiction Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Substance Abuse and Addiction Treatment Historic Market Size by Region (2020-2025)
2.2.3 Substance Abuse and Addiction Treatment Forecasted Market Size by Region (2026-2031)
2.3 Substance Abuse and Addiction Treatment Market Dynamics
2.3.1 Substance Abuse and Addiction Treatment Industry Trends
2.3.2 Substance Abuse and Addiction Treatment Market Drivers
2.3.3 Substance Abuse and Addiction Treatment Market Challenges
2.3.4 Substance Abuse and Addiction Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Substance Abuse and Addiction Treatment Players by Revenue
3.1.1 Global Top Substance Abuse and Addiction Treatment Players by Revenue (2020-2025)
3.1.2 Global Substance Abuse and Addiction Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Substance Abuse and Addiction Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Substance Abuse and Addiction Treatment Revenue
3.4 Global Substance Abuse and Addiction Treatment Market Concentration Ratio
3.4.1 Global Substance Abuse and Addiction Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Substance Abuse and Addiction Treatment Revenue in 2024
3.5 Global Key Players of Substance Abuse and Addiction Treatment Head office and Area Served
3.6 Global Key Players of Substance Abuse and Addiction Treatment, Product and Application
3.7 Global Key Players of Substance Abuse and Addiction Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Substance Abuse and Addiction Treatment Breakdown Data by Type
4.1 Global Substance Abuse and Addiction Treatment Historic Market Size by Type (2020-2025)
4.2 Global Substance Abuse and Addiction Treatment Forecasted Market Size by Type (2026-2031)
5 Substance Abuse and Addiction Treatment Breakdown Data by Application
5.1 Global Substance Abuse and Addiction Treatment Historic Market Size by Application (2020-2025)
5.2 Global Substance Abuse and Addiction Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Substance Abuse and Addiction Treatment Market Size (2020-2031)
6.2 North America Substance Abuse and Addiction Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Substance Abuse and Addiction Treatment Market Size by Country (2020-2025)
6.4 North America Substance Abuse and Addiction Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Substance Abuse and Addiction Treatment Market Size (2020-2031)
7.2 Europe Substance Abuse and Addiction Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Substance Abuse and Addiction Treatment Market Size by Country (2020-2025)
7.4 Europe Substance Abuse and Addiction Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Substance Abuse and Addiction Treatment Market Size (2020-2031)
8.2 Asia-Pacific Substance Abuse and Addiction Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Substance Abuse and Addiction Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Substance Abuse and Addiction Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Substance Abuse and Addiction Treatment Market Size (2020-2031)
9.2 Latin America Substance Abuse and Addiction Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Substance Abuse and Addiction Treatment Market Size by Country (2020-2025)
9.4 Latin America Substance Abuse and Addiction Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Substance Abuse and Addiction Treatment Market Size (2020-2031)
10.2 Middle East & Africa Substance Abuse and Addiction Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Substance Abuse and Addiction Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Substance Abuse and Addiction Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Substance Abuse and Addiction Treatment Introduction
11.1.4 Alkermes Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.1.5 Alkermes Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Details
11.2.2 Mallinckrodt Business Overview
11.2.3 Mallinckrodt Substance Abuse and Addiction Treatment Introduction
11.2.4 Mallinckrodt Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.2.5 Mallinckrodt Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Substance Abuse and Addiction Treatment Introduction
11.3.4 GSK Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Cipla Business Overview
11.4.3 Cipla Substance Abuse and Addiction Treatment Introduction
11.4.4 Cipla Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.4.5 Cipla Recent Development
11.5 Idiviour
11.5.1 Idiviour Company Details
11.5.2 Idiviour Business Overview
11.5.3 Idiviour Substance Abuse and Addiction Treatment Introduction
11.5.4 Idiviour Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.5.5 Idiviour Recent Development
11.6 Hager Biosciences,LLC
11.6.1 Hager Biosciences,LLC Company Details
11.6.2 Hager Biosciences,LLC Business Overview
11.6.3 Hager Biosciences,LLC Substance Abuse and Addiction Treatment Introduction
11.6.4 Hager Biosciences,LLC Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.6.5 Hager Biosciences,LLC Recent Development
11.7 ADDEX THERAPEUTICS
11.7.1 ADDEX THERAPEUTICS Company Details
11.7.2 ADDEX THERAPEUTICS Business Overview
11.7.3 ADDEX THERAPEUTICS Substance Abuse and Addiction Treatment Introduction
11.7.4 ADDEX THERAPEUTICS Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.7.5 ADDEX THERAPEUTICS Recent Development
11.8 Omeros Corporation
11.8.1 Omeros Corporation Company Details
11.8.2 Omeros Corporation Business Overview
11.8.3 Omeros Corporation Substance Abuse and Addiction Treatment Introduction
11.8.4 Omeros Corporation Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.8.5 Omeros Corporation Recent Development
11.9 Sosei Group Corporation
11.9.1 Sosei Group Corporation Company Details
11.9.2 Sosei Group Corporation Business Overview
11.9.3 Sosei Group Corporation Substance Abuse and Addiction Treatment Introduction
11.9.4 Sosei Group Corporation Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.9.5 Sosei Group Corporation Recent Development
11.10 CV Sciences,Inc.
11.10.1 CV Sciences,Inc. Company Details
11.10.2 CV Sciences,Inc. Business Overview
11.10.3 CV Sciences,Inc. Substance Abuse and Addiction Treatment Introduction
11.10.4 CV Sciences,Inc. Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.10.5 CV Sciences,Inc. Recent Development
11.11 Cerecor,Inc
11.11.1 Cerecor,Inc Company Details
11.11.2 Cerecor,Inc Business Overview
11.11.3 Cerecor,Inc Substance Abuse and Addiction Treatment Introduction
11.11.4 Cerecor,Inc Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.11.5 Cerecor,Inc Recent Development
11.12 Astraea Therapeutics LLC
11.12.1 Astraea Therapeutics LLC Company Details
11.12.2 Astraea Therapeutics LLC Business Overview
11.12.3 Astraea Therapeutics LLC Substance Abuse and Addiction Treatment Introduction
11.12.4 Astraea Therapeutics LLC Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.12.5 Astraea Therapeutics LLC Recent Development
11.13 Pfizer Inc
11.13.1 Pfizer Inc Company Details
11.13.2 Pfizer Inc Business Overview
11.13.3 Pfizer Inc Substance Abuse and Addiction Treatment Introduction
11.13.4 Pfizer Inc Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.13.5 Pfizer Inc Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Substance Abuse and Addiction Treatment Introduction
11.14.4 Novartis AG Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.14.5 Novartis AG Recent Development
11.15 Teva Pharmaceutical Industries Ltd
11.15.1 Teva Pharmaceutical Industries Ltd Company Details
11.15.2 Teva Pharmaceutical Industries Ltd Business Overview
11.15.3 Teva Pharmaceutical Industries Ltd Substance Abuse and Addiction Treatment Introduction
11.15.4 Teva Pharmaceutical Industries Ltd Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.15.5 Teva Pharmaceutical Industries Ltd Recent Development
11.16 Mylan NV
11.16.1 Mylan NV Company Details
11.16.2 Mylan NV Business Overview
11.16.3 Mylan NV Substance Abuse and Addiction Treatment Introduction
11.16.4 Mylan NV Revenue in Substance Abuse and Addiction Treatment Business (2020-2025)
11.16.5 Mylan NV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Substance Abuse and Addiction Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Nicotine Replacement Therapy
 Table 3. Key Players of Psychotherapy
 Table 4. Key Players of Alcohol Addiction Treatment
 Table 5. Global Substance Abuse and Addiction Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Substance Abuse and Addiction Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Substance Abuse and Addiction Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Substance Abuse and Addiction Treatment Market Share by Region (2020-2025)
 Table 9. Global Substance Abuse and Addiction Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Substance Abuse and Addiction Treatment Market Share by Region (2026-2031)
 Table 11. Substance Abuse and Addiction Treatment Market Trends
 Table 12. Substance Abuse and Addiction Treatment Market Drivers
 Table 13. Substance Abuse and Addiction Treatment Market Challenges
 Table 14. Substance Abuse and Addiction Treatment Market Restraints
 Table 15. Global Substance Abuse and Addiction Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Substance Abuse and Addiction Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Substance Abuse and Addiction Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Substance Abuse and Addiction Treatment as of 2024)
 Table 18. Ranking of Global Top Substance Abuse and Addiction Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Substance Abuse and Addiction Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Substance Abuse and Addiction Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Substance Abuse and Addiction Treatment, Product and Application
 Table 22. Global Key Players of Substance Abuse and Addiction Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Substance Abuse and Addiction Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Substance Abuse and Addiction Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Substance Abuse and Addiction Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Substance Abuse and Addiction Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Substance Abuse and Addiction Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Substance Abuse and Addiction Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Substance Abuse and Addiction Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Substance Abuse and Addiction Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Substance Abuse and Addiction Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Substance Abuse and Addiction Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Substance Abuse and Addiction Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Substance Abuse and Addiction Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Substance Abuse and Addiction Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Substance Abuse and Addiction Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Substance Abuse and Addiction Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Substance Abuse and Addiction Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Substance Abuse and Addiction Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Substance Abuse and Addiction Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Substance Abuse and Addiction Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Substance Abuse and Addiction Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Substance Abuse and Addiction Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Substance Abuse and Addiction Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Substance Abuse and Addiction Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Alkermes Company Details
 Table 48. Alkermes Business Overview
 Table 49. Alkermes Substance Abuse and Addiction Treatment Product
 Table 50. Alkermes Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 51. Alkermes Recent Development
 Table 52. Mallinckrodt Company Details
 Table 53. Mallinckrodt Business Overview
 Table 54. Mallinckrodt Substance Abuse and Addiction Treatment Product
 Table 55. Mallinckrodt Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 56. Mallinckrodt Recent Development
 Table 57. GSK Company Details
 Table 58. GSK Business Overview
 Table 59. GSK Substance Abuse and Addiction Treatment Product
 Table 60. GSK Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 61. GSK Recent Development
 Table 62. Cipla Company Details
 Table 63. Cipla Business Overview
 Table 64. Cipla Substance Abuse and Addiction Treatment Product
 Table 65. Cipla Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 66. Cipla Recent Development
 Table 67. Idiviour Company Details
 Table 68. Idiviour Business Overview
 Table 69. Idiviour Substance Abuse and Addiction Treatment Product
 Table 70. Idiviour Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 71. Idiviour Recent Development
 Table 72. Hager Biosciences,LLC Company Details
 Table 73. Hager Biosciences,LLC Business Overview
 Table 74. Hager Biosciences,LLC Substance Abuse and Addiction Treatment Product
 Table 75. Hager Biosciences,LLC Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 76. Hager Biosciences,LLC Recent Development
 Table 77. ADDEX THERAPEUTICS Company Details
 Table 78. ADDEX THERAPEUTICS Business Overview
 Table 79. ADDEX THERAPEUTICS Substance Abuse and Addiction Treatment Product
 Table 80. ADDEX THERAPEUTICS Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 81. ADDEX THERAPEUTICS Recent Development
 Table 82. Omeros Corporation Company Details
 Table 83. Omeros Corporation Business Overview
 Table 84. Omeros Corporation Substance Abuse and Addiction Treatment Product
 Table 85. Omeros Corporation Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 86. Omeros Corporation Recent Development
 Table 87. Sosei Group Corporation Company Details
 Table 88. Sosei Group Corporation Business Overview
 Table 89. Sosei Group Corporation Substance Abuse and Addiction Treatment Product
 Table 90. Sosei Group Corporation Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 91. Sosei Group Corporation Recent Development
 Table 92. CV Sciences,Inc. Company Details
 Table 93. CV Sciences,Inc. Business Overview
 Table 94. CV Sciences,Inc. Substance Abuse and Addiction Treatment Product
 Table 95. CV Sciences,Inc. Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 96. CV Sciences,Inc. Recent Development
 Table 97. Cerecor,Inc Company Details
 Table 98. Cerecor,Inc Business Overview
 Table 99. Cerecor,Inc Substance Abuse and Addiction Treatment Product
 Table 100. Cerecor,Inc Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 101. Cerecor,Inc Recent Development
 Table 102. Astraea Therapeutics LLC Company Details
 Table 103. Astraea Therapeutics LLC Business Overview
 Table 104. Astraea Therapeutics LLC Substance Abuse and Addiction Treatment Product
 Table 105. Astraea Therapeutics LLC Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 106. Astraea Therapeutics LLC Recent Development
 Table 107. Pfizer Inc Company Details
 Table 108. Pfizer Inc Business Overview
 Table 109. Pfizer Inc Substance Abuse and Addiction Treatment Product
 Table 110. Pfizer Inc Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 111. Pfizer Inc Recent Development
 Table 112. Novartis AG Company Details
 Table 113. Novartis AG Business Overview
 Table 114. Novartis AG Substance Abuse and Addiction Treatment Product
 Table 115. Novartis AG Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 116. Novartis AG Recent Development
 Table 117. Teva Pharmaceutical Industries Ltd Company Details
 Table 118. Teva Pharmaceutical Industries Ltd Business Overview
 Table 119. Teva Pharmaceutical Industries Ltd Substance Abuse and Addiction Treatment Product
 Table 120. Teva Pharmaceutical Industries Ltd Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 121. Teva Pharmaceutical Industries Ltd Recent Development
 Table 122. Mylan NV Company Details
 Table 123. Mylan NV Business Overview
 Table 124. Mylan NV Substance Abuse and Addiction Treatment Product
 Table 125. Mylan NV Revenue in Substance Abuse and Addiction Treatment Business (2020-2025) & (US$ Million)
 Table 126. Mylan NV Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Substance Abuse and Addiction Treatment Picture
 Figure 2. Global Substance Abuse and Addiction Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Substance Abuse and Addiction Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Nicotine Replacement Therapy Features
 Figure 5. Psychotherapy Features
 Figure 6. Alcohol Addiction Treatment Features
 Figure 7. Global Substance Abuse and Addiction Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Substance Abuse and Addiction Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Home Nursing Case Studies
 Figure 11. Specialist Clinic Case Studies
 Figure 12. Other Case Studies
 Figure 13. Substance Abuse and Addiction Treatment Report Years Considered
 Figure 14. Global Substance Abuse and Addiction Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Substance Abuse and Addiction Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Substance Abuse and Addiction Treatment Market Share by Region: 2024 VS 2031
 Figure 17. Global Substance Abuse and Addiction Treatment Market Share by Players in 2024
 Figure 18. Global Top Substance Abuse and Addiction Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Substance Abuse and Addiction Treatment as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Substance Abuse and Addiction Treatment Revenue in 2024
 Figure 20. North America Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Substance Abuse and Addiction Treatment Market Share by Country (2020-2031)
 Figure 22. United States Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Substance Abuse and Addiction Treatment Market Share by Country (2020-2031)
 Figure 26. Germany Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Substance Abuse and Addiction Treatment Market Share by Region (2020-2031)
 Figure 34. China Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Substance Abuse and Addiction Treatment Market Share by Country (2020-2031)
 Figure 42. Mexico Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Substance Abuse and Addiction Treatment Market Share by Country (2020-2031)
 Figure 46. Turkey Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Substance Abuse and Addiction Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Alkermes Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 50. Mallinckrodt Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 51. GSK Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 52. Cipla Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 53. Idiviour Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 54. Hager Biosciences,LLC Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 55. ADDEX THERAPEUTICS Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 56. Omeros Corporation Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 57. Sosei Group Corporation Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 58. CV Sciences,Inc. Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 59. Cerecor,Inc Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 60. Astraea Therapeutics LLC Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 61. Pfizer Inc Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 62. Novartis AG Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 63. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 64. Mylan NV Revenue Growth Rate in Substance Abuse and Addiction Treatment Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS